 NEW YORK, May 19, 2021 GLOBE NEWSWIRE -- Applied Therapeutics, Inc. Nasdaq: APLT, a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, announced today that it will present at the UBS Global Healthcare Virtual Conference on Tuesday, May 25, 2021 at 10:00 a.m. ET. 